These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 18647556)

  • 1. [Serum levels of Apo-AI and B as markers of synthetic graft stenosis after bypass for peripheral artery disease].
    Guzmán-Lepe S; Anaya-Prado R
    Cir Cir; 2008; 76(3):225-33. PubMed ID: 18647556
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Apo B/Apo A-I ratio in central and peripheral arterial diseases.
    Lima LM; Carvalho Md; Sabino Ade P; Mota AP; Fernandes AP; Sousa MO
    Arq Bras Endocrinol Metabol; 2007 Oct; 51(7):1160-5. PubMed ID: 18157393
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of apolipoprotein-B/apolipoprotein-AI in subjects with versus without the metabolic syndrome.
    Sierra-Johnson J; Somers VK; Kuniyoshi FH; Garza CA; Isley WL; Gami AS; Lopez-Jimenez F
    Am J Cardiol; 2006 Nov; 98(10):1369-73. PubMed ID: 17134631
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between plasma lipids, and apolipoproteins and coronary artery disease: a cross-sectional study in a low-risk Korean population.
    Kim HK; Chang SA; Choi EK; Kim YJ; Kim HS; Sohn DW; Oh BH; Lee MM; Park YB; Choi YS
    Int J Cardiol; 2005 Jun; 101(3):435-40. PubMed ID: 15907412
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A two-year clinical study of the effects of two triphasic oral contraceptives on plasma lipids.
    Kakis G; Powell M; Marshall A; Woutersz TB; Steiner G
    Int J Fertil Menopausal Stud; 1994; 39(5):283-91. PubMed ID: 7820162
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetics of apolipoprotein B and apolipoprotein AI and premature coronary artery disease.
    Zambon A; Brown BG; Deeb SS; Brunzell JD
    J Intern Med; 2006 May; 259(5):473-80. PubMed ID: 16629853
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Four-year randomized prospective comparison of percutaneous ePTFE/nitinol self-expanding stent graft versus prosthetic femoral-popliteal bypass in the treatment of superficial femoral artery occlusive disease.
    McQuade K; Gable D; Pearl G; Theune B; Black S
    J Vasc Surg; 2010 Sep; 52(3):584-90; discussion 590-1, 591.e1-591.e7. PubMed ID: 20598480
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Selected new atherosclerosis risk factors and markers of fibrinolysis in children and adolescents with obesity, hypertension and diabetes].
    Głowińska B; Urban M; Koput A; Galar M
    Przegl Lek; 2003; 60(1):12-7. PubMed ID: 12884639
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between Apolipoprotein B/Apolipoprotein A-1 and arterial stiffness in metabolic syndrome.
    Kim MK; Ahn CW; Kang S; Ha JY; Baek H; Park JS; Kim KR
    Clin Chim Acta; 2014 Nov; 437():115-9. PubMed ID: 25025299
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Randomized comparison of ePTFE/nitinol self-expanding stent graft vs prosthetic femoral-popliteal bypass in the treatment of superficial femoral artery occlusive disease.
    McQuade K; Gable D; Hohman S; Pearl G; Theune B
    J Vasc Surg; 2009 Jan; 49(1):109-15, 116.e1-9; discussion 116. PubMed ID: 19028055
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reference distributions for apolipoproteins AI and B and the apolipoprotein B/AI ratios: a practical and clinically relevant approach in a large cohort.
    Ritchie RF; Palomaki GE; Neveux LM; Ledue TB; Craig WY; Marcovina S; Navolotskaia O
    J Clin Lab Anal; 2006; 20(5):209-17. PubMed ID: 16960896
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Plasma apolipoproteins B and AI in healthy individuals and patients with coronary atherosclerosis in a male population from Lithuania].
    Stakishaĭtis DV; Ivashkiavichenie LI; Kameneva AM
    Kardiologiia; 1991 Oct; 31(10):33-6. PubMed ID: 1753578
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical significance of apolipoprotein B and AI determinations in coronary heart disease].
    Li JZ; Wang JJ; Niu QT
    Zhonghua Nei Ke Za Zhi; 1989 Jun; 28(6):351-5, 381-2. PubMed ID: 2510981
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Assessment of metabolic atherosclerosis risk factors in progeny of patients with past ischemic stroke].
    Mierzecki A; Bukowska H; Honczarenko K; Jastrzebska M; Millo B; Torbus-Lisiecka B
    Pol Arch Med Wewn; 2005 Feb; 113(2):119-29. PubMed ID: 16209232
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elevated lipoprotein (a) and apolipoprotein B to AI ratio in South Asian patients with ischaemic stroke.
    Sharobeem KM; Patel JV; Ritch AE; Lip GY; Gill PS; Hughes EA
    Int J Clin Pract; 2007 Nov; 61(11):1824-8. PubMed ID: 17935546
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factors behind the increase in cardiovascular mortality in Russia: apolipoprotein AI and B distribution in the Arkhangelsk study 2000.
    Averina M; Nilssen O; Brenn T; Brox J; Arkhipovsky VL; Kalinin AG
    Clin Chem; 2004 Feb; 50(2):346-54. PubMed ID: 14684620
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Measurement and meaning of apolipoprotein AI and apolipoprotein B plasma levels.
    Marcovina S; Packard CJ
    J Intern Med; 2006 May; 259(5):437-46. PubMed ID: 16629849
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Apolipoproteins C-II and C-III in peripheral arterial disease.
    Alessandri C; Basili S; Maurelli M; Andreozzi P; Colletta A; Paradiso M; Cordova C
    Angiology; 1994 Feb; 45(2):131-6. PubMed ID: 8129188
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The associations between apolipoprotein B, A1, and the B/A1 ratio and nonalcoholic fatty liver disease in both normal-weight and overweight Korean population.
    Yang MH; Sung J; Gwak GY
    J Clin Lipidol; 2016; 10(2):289-98. PubMed ID: 27055959
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Apolipoprotein B-containing lipoproteins in renal failure: the relation to mode of dialysis.
    Attman PO; Samuelsson OG; Moberly J; Johansson AC; Ljungman S; Weiss LG; Knight-Gibson C; Alaupovic P
    Kidney Int; 1999 Apr; 55(4):1536-42. PubMed ID: 10201020
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.